Skip to main content
Clinical Trials/ACTRN12623001092684
ACTRN12623001092684
Not Yet Recruiting
Phase 1

Safety and feasibility of Poly Aryl Ether Ketone (PAEK) Implant for Contour Restoration in Jaw Reconstruction. A Pilot Trial

Chris O'Brien Lifehouse0 sites12 target enrollmentOctober 18, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Jaw reconstruction
Sponsor
Chris O'Brien Lifehouse
Enrollment
12
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 18, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 years and older
  • Head and neck cancer
  • Undergoing fibula free flap reconstruction of the mandible where there is a \> 10 mm deficit in the mandible contour that would normally (without the PAEK implant) result in asymmetry
  • Willingness to give informed consent

Exclusion Criteria

  • Active soft tissue infection or osteomyelitis
  • Less than 18 years of age
  • Previously undergone renal or any other allogeneic transplantation and on high dose immunosuppressive therapy
  • Unable to give informed medical consent due to cognitive impairment of psychiatric illness
  • Current or recent drug and/or alcohol abusers
  • On high dose immunosuppressive therapy including high dose steroids and methotrexate
  • A history of an endocrine, connective tissue, or metabolic disorder known to severely affect osteogenesis (e.g., Paget’s Disease, renal osteodystrophy, Ehlers\- Danlos Syndrome, or osteogenesis imperfecta)
  • On other clinical trials who have received treatment with an investigational therapy within 28 days prior to reconstructive surgery or where treatment is planned during or after the follow up period

Outcomes

Primary Outcomes

Not specified

Similar Trials